Jean Elwing, MD, FCCP

Jean Elwing, MD, FCCP

At CHEST 2023, October 8 to 11 in Hawaiʻi, you’ll get vital updates on many of the most talked-about topics in cardiovascular and pulmonary vascular medicine. During the 4-day program, you’ll learn new strategies for navigating the opportunities and challenges that come up in your daily clinical work.

Cardiovascular and Pulmonary Vascular Medicine Curriculum Group Chair, Jean Elwing, MD, FCCP, selected a few of the most essential cardiovascular and pulmonary vascular medicine sessions to put on your calendar. To see what else is in store, browse the full educational program.

“You’ll have unique opportunities to learn in multidisciplinary ways at CHEST 2023. You will have opportunities to interact with content experts in ways you might not be able to at other meetings,” Dr. Elwing said.

“I invite anyone who’s interested in the pulmonary vascular or cardiovascular space to join us at the meeting. We have a fabulous curriculum set up for you, and I know you’ll have a great learning experience—plus you’ll have a lot of fun.”

Follow-up After Acute Pulmonary Embolism and the SEARCH Algorithm: A Rapid-Fire Discussion
It can be challenging to follow patients with pulmonary embolism (PE) on a long-term basis. You’ll leave this session with a better understanding of how to assess and monitor patients with this disease over time.

More from Dr. Elwing: “Learners will enjoy this higher-level session. It will go through the whole continuum of pulmonary embolism. Through this expert discussion, I'm hoping that people will leave with a better understanding of how to watch these patients and when to send them on to expert pulmonary embolism centers for further workup.”

An Innovative, Highly Interactive Discussion of Intermediate-Risk Pulmonary Embolism
During this panel discussion designed for early career clinicians, you’ll learn how to better evaluate and treat patients with intermediate-risk PE. The session will cover topics including PE risk stratification, catheter-based treatments, and multidisciplinary care in PE management.

Acute Right Ventricular Failure Management: Different Training, Different Approaches
This highly anticipated session will combine a pro-con debate with case-based discussions on acute right ventricular failure (RVF) management. Learn the best initial right ventricular support strategies in severe RVF and ideal modalities to diagnose RVF.

Debates on the Management of Massive Pulmonary Embolism: Cracking the Clot
Hear expert perspectives on the management of massive PE that can impact your day-to-day practice. Get the latest developments on discontinuing anticoagulation after PE, post-PE syndromes, and uses for balloon pulmonary angioplasty and pulmonary thromboendarterectomy.

Is This Really PAH? – My Spidey Sense Is Tingling
Differentiating between pulmonary arterial hypertension (PAH) and other disease states is a frequent clinical conundrum. CHEST faculty—including a fellow-in-training presenter—will help you distinguish between PAH, pulmonary hypertension due to left heart disease, and pulmonary hypertension associated with interstitial lung disease.

More from Dr. Elwing: “This session is focused on investigating a patient who’s dyspneic and trying to figure out if they have pulmonary arterial hypertension or another form of pulmonary hypertension. Once you’ve fully evaluated a patient, then you can go on to further assess and initiate optimal treatment.”

Join thousands of chest medicine clinicians in getting the most cutting-edge education in cardiovascular and pulmonary vascular medicine at CHEST 2023, October 8 to 11, in Honolulu, Hawaiʻi.

LEARN MORE